TRACER PHARMA ApS: Financial statements 2015
CVR: 34090106
Source: annual report 2015, Danish Business Authority
01/05/2014 – 30/04/2015
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 2,168,728 and a net result of DKK 30,108 compared with DKK 123,200 the year before. That is an increase of 7.5% compared with the year before. Equity in the 2015 report amounted to DKK 114,087. The solvency ratio was 2.3%.
- Gross Profit
- DKK 2,168,728
- Profit/Loss
- DKK 30,108
- Equity
- DKK 114,087
- Total Assets
- DKK 4,909,587
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 2.2 mio. | 30 t. | 114 t. | - |
| 2014 | - | 2 mio. | 123 t. | 204 t. | - |
Official annual report
How creditworthy is TRACER PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.